132 related articles for article (PubMed ID: 37090448)
1. Breast, cervical, and lung cancer: A comparison of real healthcare costs and INA-CBGs rates in the era of national health insurance.
Yuliastuti F; Andayani TM; Endarti D; Kristina SA
Pharm Pract (Granada); 2023; 21(1):2768. PubMed ID: 37090448
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Real Cost Versus the Indonesian Case Base Groups (INA-CBGs) Tariff Rates Among Patients of High- Incidence Cancers Under the National Health Insurance Scheme.
Satibi S; Andayani TM; Endarti D; Suwantara IPT; Agustini NPD
Asian Pac J Cancer Prev; 2019 Jan; 20(1):117-122. PubMed ID: 30678390
[TBL] [Abstract][Full Text] [Related]
3. INA-CBGs claim versus total hospital cost: A vaginal delivery investigation at Airlangga University Academic Hospital, Indonesia.
Wardhana MP; Gumilar KE; Rahmadhany P; Rosita Dewi E; Laksana MAC
J Public Health Res; 2020 Oct; 9(4):1999. PubMed ID: 33409246
[No Abstract] [Full Text] [Related]
4. Application of Failure Mode and Effects Analysis in Managing Medical Records for Accuracy of INA-CBGs Health Insurance Claims in a Tertiary Hospital in Indonesia.
Marpaung Y; Taifur WD; Syah NA; Yusuf Y
Perspect Health Inf Manag; 2022; 19(3):1g. PubMed ID: 36035333
[TBL] [Abstract][Full Text] [Related]
5. Does the Implementation of a National Health Insurance Program Result in Rationing Care for Ischemic Stroke Management? Analysis of the Indonesian National Health Insurance Program.
Amalia L
Risk Manag Healthc Policy; 2023; 16():455-461. PubMed ID: 37007298
[TBL] [Abstract][Full Text] [Related]
6. Healthcare Quality Received by Insured Patients in Two Indonesian Regional Public Hospitals.
Rachmawaty R; Wahyudin E; Bukhari A; Sinrang AW; Satar GL; Juhran A
J Holist Nurs; 2024 Feb; ():8980101241229481. PubMed ID: 38311909
[No Abstract] [Full Text] [Related]
7. The Development of Quality of Life Questionnaire for Indonesian Breast Cancer Patients: INA-BCHRQoL.
Saptaningsih AB; Setiawan D; Rivany R; Aryandono T; Atthobari J; Dwiprahasto I
Asian Pac J Cancer Prev; 2018 May; 19(5):1269-1275. PubMed ID: 29801412
[TBL] [Abstract][Full Text] [Related]
8. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
9. Cost Analysis of Cervical Cancer Patients with Different Medical Payment Modes Based on Gamma Model within a Grade A Tertiary Hospital.
Wu SW; Chen T; Pan Q; Wei LY; Wang Q; Song JC; Li C; Luo J
Chin Med J (Engl); 2018 Feb; 131(4):389-394. PubMed ID: 29451142
[TBL] [Abstract][Full Text] [Related]
10. Rationing for medicines by health care providers in Indonesia National Health Insurance System at hospital setting: a qualitative study.
Yuniarti E; Prabandari YS; Kristin E; Suryawati S
J Pharm Policy Pract; 2019; 12():7. PubMed ID: 31080624
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Treatment Costs for Breast Cancer, by Tumor Stage and Type of Service.
Blumen H; Fitch K; Polkus V
Am Health Drug Benefits; 2016 Feb; 9(1):23-32. PubMed ID: 27066193
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Worker's Compensation Claims on Outcomes and Costs Following an Anterior Cervical Discectomy and Fusion.
Tabaraee E; Ahn J; Bohl DD; Elboghdady IM; Aboushaala K; Singh K
Spine (Phila Pa 1976); 2015 Jun; 40(12):948-53. PubMed ID: 26070041
[TBL] [Abstract][Full Text] [Related]
13. Cost analysis in total hip arthroplasty: experience of a teaching medical center located in Paris.
Lernout T; Labalette C; Sedel L; Kormann P; Duteil C; Le Divenah A; Bertrand D; David S; Segouin C
Orthop Traumatol Surg Res; 2010 Apr; 96(2):113-23. PubMed ID: 20417909
[TBL] [Abstract][Full Text] [Related]
14. Use of Drugs in Clinical Practice and the Associated Cost of Cancer Treatment in Adult Patients with Solid Tumors: A 10-Year Retrospective Cohort Study.
Carreras MJ; Tomás-Guillén E; Farriols A; Renedo-Miró B; Valdivia C; Vidal J; Saura C; Carles J; Felip E; Gorgas MQ; Tabernero J; Monterde J
Curr Oncol; 2023 Aug; 30(9):7984-8004. PubMed ID: 37754495
[TBL] [Abstract][Full Text] [Related]
15. Real-world comparison of healthcare resource utilization and costs of [
Cox T; O'Connell M; Leeuwenkamp O; Palimaka S; Reed N
Curr Med Res Opin; 2022 Aug; 38(8):1305-1317. PubMed ID: 35418254
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Yıldız M; Osman E
Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
[TBL] [Abstract][Full Text] [Related]
18. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
